Original language | English |
---|---|
Pages (from-to) | 928-930 |
Number of pages | 3 |
Journal | Neurology |
Volume | 78 |
Issue number | 12 |
DOIs | |
State | Published - 20 Mar 2012 |
Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Neurology, Vol. 78, No. 12, 20.03.2012, p. 928-930.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Clinical/scientific notes
AU - Castrop, F.
AU - Kowarik, M. C.
AU - Albrecht, H.
AU - Krause, M.
AU - Haslinger, B.
AU - Zimmer, C.
AU - Berthele, A.
AU - Hemmer, B.
N1 - Funding Information: Dr. Castrop has received funding for travel from Allergan, Biogen Idec, Ipsen, Medtronic, Merck Serono, Merz Pharmaceuticals, Novartis, and Solvay. Dr. Kowarik has received research support from Novartis and has received funding for travel from Merck Serono and Bayer Schering Pharma. Dr. Albrecht has received funding for research from Novartis and funding for travel from Merck Serono, Teva, Biogen Idec, Bayer Schering Pharma, and Novartis. Dr. Krause has received funding for research from Novartis and funding for advisory boards, funding for travel, and speaker honoraria from Merck Serono, Teva, Biogen Idec, Bayer Schering Pharma, Novartis, and Merz Pharmaceuticals. Dr. Haslinger has served on a scientific advisory board for Merz Pharmaceuticals; received funding for travel from Biogen Idec, Ipsen, Medtronic, and Merz Pharmaceuticals; has received speaker honoraria from Allergan, Desitin Pharmaceuticals, GlaxoSmithKline, Ipsen, and Novartis; and receives research support from Ipsen and the German Research Foundation (DFG). Dr. Zimmer has received funding for research from ACI Immune S.A., Actelion Pharmaceuticals, Affiris, Biogen Idec, Concentric Medical, FGK Clinical Research, Genzyme, Invade, Medivation, Medtronic Spinal and Biologics Europe, NeuroRx Research, Novartis, Omnicare Clinical Research, Galapagos NV, Penumbra, Pfizer, Pharmtrace, Premier Research Germany, Qintiles, Reverse Medical, Roche, and Surpass Medical; and receives research support from the German Research Foundation (DFG and BMBF) and the Bavarian Research Foundation . Dr. Berthele has received funding for travel and speaker honoraria from Biogen Idec, Merck Serono, Novartis, Teva, and Bayer Schering Pharma; and has received funding for research from Bayer Schering Pharma . Dr. Hemmer has served on scientific advisory boards for and received funding for travel or speaker honoraria from Novartis, Bayer Schering Pharma, Biogen Idec, Merck Serono, Roche, Micromet and Novartis; serves as a consultant for Gerson Lehrman Group; and has received research support from Novartis, Roche, Bayer Schering Pharma, Biogen Idec, Metanomics, Protagen, Merck Serono, DFG, BMBF, and Hertie Foundation.
PY - 2012/3/20
Y1 - 2012/3/20
UR - http://www.scopus.com/inward/record.url?scp=84860344893&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e31824c46ad
DO - 10.1212/WNL.0b013e31824c46ad
M3 - Article
C2 - 22402856
AN - SCOPUS:84860344893
SN - 0028-3878
VL - 78
SP - 928
EP - 930
JO - Neurology
JF - Neurology
IS - 12
ER -